nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP3A4—Everolimus—kidney cancer	0.0801	0.135	CbGbCtD
Fenofibrate—CYP2C8—Pazopanib—kidney cancer	0.0701	0.118	CbGbCtD
Fenofibrate—CYP3A4—Temsirolimus—kidney cancer	0.0541	0.0915	CbGbCtD
Fenofibrate—CYP2C9—Capecitabine—kidney cancer	0.051	0.0862	CbGbCtD
Fenofibrate—CYP2C8—Erlotinib—kidney cancer	0.05	0.0845	CbGbCtD
Fenofibrate—CYP2C8—Paclitaxel—kidney cancer	0.0458	0.0774	CbGbCtD
Fenofibrate—CYP2C8—Sorafenib—kidney cancer	0.0407	0.0687	CbGbCtD
Fenofibrate—CYP2C9—Paclitaxel—kidney cancer	0.0319	0.054	CbGbCtD
Fenofibrate—CYP3A4—Pazopanib—kidney cancer	0.0284	0.0481	CbGbCtD
Fenofibrate—CYP2C9—Sorafenib—kidney cancer	0.0284	0.0479	CbGbCtD
Fenofibrate—CYP3A4—Erlotinib—kidney cancer	0.0203	0.0343	CbGbCtD
Fenofibrate—CYP3A4—Paclitaxel—kidney cancer	0.0186	0.0314	CbGbCtD
Fenofibrate—CYP3A4—Sorafenib—kidney cancer	0.0165	0.0279	CbGbCtD
Fenofibrate—CYP3A4—Vinblastine—kidney cancer	0.0163	0.0275	CbGbCtD
Fenofibrate—CYP3A4—Vincristine—kidney cancer	0.016	0.0271	CbGbCtD
Fenofibrate—CYP3A4—Sunitinib—kidney cancer	0.0134	0.0226	CbGbCtD
Fenofibrate—CYP3A4—Doxorubicin—kidney cancer	0.01	0.0169	CbGbCtD
Fenofibrate—Clofibrate—CYP1A1—kidney cancer	0.0013	0.339	CrCbGaD
Fenofibrate—Bezafibrate—CYP1A1—kidney cancer	0.000948	0.248	CrCbGaD
Fenofibrate—Indomethacin—PTGS1—kidney cancer	0.000768	0.201	CrCbGaD
Fenofibrate—Indomethacin—PTGS2—kidney cancer	0.000439	0.115	CrCbGaD
Fenofibrate—Indomethacin—ABCB1—kidney cancer	0.000373	0.0975	CrCbGaD
Fenofibrate—Diarrhoea—Sorafenib—kidney cancer	0.000134	0.000367	CcSEcCtD
Fenofibrate—Hypertension—Paclitaxel—kidney cancer	0.000134	0.000367	CcSEcCtD
Fenofibrate—Pruritus—Sunitinib—kidney cancer	0.000134	0.000365	CcSEcCtD
Fenofibrate—Angiopathy—Capecitabine—kidney cancer	0.000133	0.000364	CcSEcCtD
Fenofibrate—Myalgia—Paclitaxel—kidney cancer	0.000132	0.000362	CcSEcCtD
Fenofibrate—Chest pain—Paclitaxel—kidney cancer	0.000132	0.000362	CcSEcCtD
Fenofibrate—Arthralgia—Paclitaxel—kidney cancer	0.000132	0.000362	CcSEcCtD
Fenofibrate—Mediastinal disorder—Capecitabine—kidney cancer	0.000132	0.000361	CcSEcCtD
Fenofibrate—Anxiety—Paclitaxel—kidney cancer	0.000132	0.000361	CcSEcCtD
Fenofibrate—Decreased appetite—Gemcitabine—kidney cancer	0.000132	0.00036	CcSEcCtD
Fenofibrate—Hypersensitivity—Dactinomycin—kidney cancer	0.000132	0.00036	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000131	0.000359	CcSEcCtD
Fenofibrate—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000131	0.00339	CbGpPWpGaD
Fenofibrate—Arrhythmia—Capecitabine—kidney cancer	0.000131	0.000358	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000131	0.000358	CcSEcCtD
Fenofibrate—Discomfort—Paclitaxel—kidney cancer	0.000131	0.000358	CcSEcCtD
Fenofibrate—Fatigue—Gemcitabine—kidney cancer	0.000131	0.000357	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Vincristine—kidney cancer	0.000131	0.000357	CcSEcCtD
Fenofibrate—Dizziness—Sorafenib—kidney cancer	0.00013	0.000355	CcSEcCtD
Fenofibrate—Pain—Gemcitabine—kidney cancer	0.00013	0.000354	CcSEcCtD
Fenofibrate—Constipation—Gemcitabine—kidney cancer	0.00013	0.000354	CcSEcCtD
Fenofibrate—Nausea—Erlotinib—kidney cancer	0.00013	0.000354	CcSEcCtD
Fenofibrate—Alopecia—Capecitabine—kidney cancer	0.00013	0.000354	CcSEcCtD
Fenofibrate—Dry mouth—Paclitaxel—kidney cancer	0.000129	0.000354	CcSEcCtD
Fenofibrate—Diarrhoea—Sunitinib—kidney cancer	0.000129	0.000353	CcSEcCtD
Fenofibrate—Mental disorder—Capecitabine—kidney cancer	0.000128	0.000351	CcSEcCtD
Fenofibrate—Asthenia—Dactinomycin—kidney cancer	0.000128	0.000351	CcSEcCtD
Fenofibrate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000128	0.00332	CbGpPWpGaD
Fenofibrate—Blood creatinine increased—Doxorubicin—kidney cancer	0.000128	0.00035	CcSEcCtD
Fenofibrate—Malnutrition—Capecitabine—kidney cancer	0.000128	0.000349	CcSEcCtD
Fenofibrate—Erythema—Capecitabine—kidney cancer	0.000128	0.000349	CcSEcCtD
Fenofibrate—Oedema—Paclitaxel—kidney cancer	0.000127	0.000347	CcSEcCtD
Fenofibrate—Abdominal pain—Vincristine—kidney cancer	0.000126	0.000345	CcSEcCtD
Fenofibrate—Body temperature increased—Vincristine—kidney cancer	0.000126	0.000345	CcSEcCtD
Fenofibrate—Liver function test abnormal—Doxorubicin—kidney cancer	0.000126	0.000345	CcSEcCtD
Fenofibrate—Infection—Paclitaxel—kidney cancer	0.000126	0.000345	CcSEcCtD
Fenofibrate—Flatulence—Capecitabine—kidney cancer	0.000126	0.000344	CcSEcCtD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000125	0.00324	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—CTNNA1—kidney cancer	0.000125	0.00323	CbGpPWpGaD
Fenofibrate—Dizziness—Sunitinib—kidney cancer	0.000125	0.000341	CcSEcCtD
Fenofibrate—Feeling abnormal—Gemcitabine—kidney cancer	0.000125	0.000341	CcSEcCtD
Fenofibrate—Vomiting—Sorafenib—kidney cancer	0.000125	0.000341	CcSEcCtD
Fenofibrate—Nervous system disorder—Paclitaxel—kidney cancer	0.000124	0.00034	CcSEcCtD
Fenofibrate—Thrombocytopenia—Paclitaxel—kidney cancer	0.000124	0.00034	CcSEcCtD
Fenofibrate—PPARA—Metabolism—CCBL1—kidney cancer	0.000124	0.00321	CbGpPWpGaD
Fenofibrate—Tachycardia—Paclitaxel—kidney cancer	0.000124	0.000339	CcSEcCtD
Fenofibrate—Rash—Sorafenib—kidney cancer	0.000124	0.000338	CcSEcCtD
Fenofibrate—Dermatitis—Sorafenib—kidney cancer	0.000124	0.000338	CcSEcCtD
Fenofibrate—Back pain—Capecitabine—kidney cancer	0.000123	0.000337	CcSEcCtD
Fenofibrate—Skin disorder—Paclitaxel—kidney cancer	0.000123	0.000337	CcSEcCtD
Fenofibrate—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000123	0.000336	CcSEcCtD
Fenofibrate—Headache—Sorafenib—kidney cancer	0.000123	0.000336	CcSEcCtD
Fenofibrate—Muscle spasms—Capecitabine—kidney cancer	0.000123	0.000335	CcSEcCtD
Fenofibrate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000123	0.000335	CcSEcCtD
Fenofibrate—Diarrhoea—Dactinomycin—kidney cancer	0.000122	0.000334	CcSEcCtD
Fenofibrate—Nasopharyngitis—Doxorubicin—kidney cancer	0.000122	0.000334	CcSEcCtD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000122	0.00316	CbGpPWpGaD
Fenofibrate—Anorexia—Paclitaxel—kidney cancer	0.000121	0.000331	CcSEcCtD
Fenofibrate—Gastritis—Doxorubicin—kidney cancer	0.000121	0.00033	CcSEcCtD
Fenofibrate—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00012	0.000329	CcSEcCtD
Fenofibrate—Muscular weakness—Doxorubicin—kidney cancer	0.00012	0.000329	CcSEcCtD
Fenofibrate—Vomiting—Sunitinib—kidney cancer	0.00012	0.000328	CcSEcCtD
Fenofibrate—Body temperature increased—Gemcitabine—kidney cancer	0.00012	0.000328	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—PAX6—kidney cancer	0.00012	0.0031	CbGpPWpGaD
Fenofibrate—Rash—Sunitinib—kidney cancer	0.000119	0.000326	CcSEcCtD
Fenofibrate—Dermatitis—Sunitinib—kidney cancer	0.000119	0.000325	CcSEcCtD
Fenofibrate—Hypotension—Paclitaxel—kidney cancer	0.000119	0.000324	CcSEcCtD
Fenofibrate—Ill-defined disorder—Capecitabine—kidney cancer	0.000118	0.000324	CcSEcCtD
Fenofibrate—Headache—Sunitinib—kidney cancer	0.000118	0.000323	CcSEcCtD
Fenofibrate—Asthma—Doxorubicin—kidney cancer	0.000118	0.000323	CcSEcCtD
Fenofibrate—Influenza—Doxorubicin—kidney cancer	0.000118	0.000323	CcSEcCtD
Fenofibrate—Anaemia—Capecitabine—kidney cancer	0.000118	0.000322	CcSEcCtD
Fenofibrate—Hypersensitivity—Vincristine—kidney cancer	0.000118	0.000322	CcSEcCtD
Fenofibrate—PPARA—Adipogenesis—CTNNB1—kidney cancer	0.000118	0.00304	CbGpPWpGaD
Fenofibrate—Eosinophilia—Doxorubicin—kidney cancer	0.000117	0.00032	CcSEcCtD
Fenofibrate—Nausea—Sorafenib—kidney cancer	0.000117	0.000319	CcSEcCtD
Fenofibrate—Pancreatitis—Doxorubicin—kidney cancer	0.000116	0.000316	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000116	0.000316	CcSEcCtD
Fenofibrate—Malaise—Capecitabine—kidney cancer	0.000115	0.000315	CcSEcCtD
Fenofibrate—Angina pectoris—Doxorubicin—kidney cancer	0.000115	0.000314	CcSEcCtD
Fenofibrate—Insomnia—Paclitaxel—kidney cancer	0.000115	0.000314	CcSEcCtD
Fenofibrate—Vertigo—Capecitabine—kidney cancer	0.000115	0.000313	CcSEcCtD
Fenofibrate—Asthenia—Vincristine—kidney cancer	0.000115	0.000313	CcSEcCtD
Fenofibrate—Leukopenia—Capecitabine—kidney cancer	0.000114	0.000312	CcSEcCtD
Fenofibrate—Paraesthesia—Paclitaxel—kidney cancer	0.000114	0.000312	CcSEcCtD
Fenofibrate—Vomiting—Dactinomycin—kidney cancer	0.000114	0.000311	CcSEcCtD
Fenofibrate—Bronchitis—Doxorubicin—kidney cancer	0.000114	0.00031	CcSEcCtD
Fenofibrate—Dyspnoea—Paclitaxel—kidney cancer	0.000113	0.000309	CcSEcCtD
Fenofibrate—Somnolence—Paclitaxel—kidney cancer	0.000113	0.000308	CcSEcCtD
Fenofibrate—Palpitations—Capecitabine—kidney cancer	0.000113	0.000308	CcSEcCtD
Fenofibrate—Rash—Dactinomycin—kidney cancer	0.000113	0.000308	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000112	0.00291	CbGpPWpGaD
Fenofibrate—Nausea—Sunitinib—kidney cancer	0.000112	0.000307	CcSEcCtD
Fenofibrate—Dyspepsia—Paclitaxel—kidney cancer	0.000112	0.000305	CcSEcCtD
Fenofibrate—Cough—Capecitabine—kidney cancer	0.000111	0.000304	CcSEcCtD
Fenofibrate—Dysuria—Doxorubicin—kidney cancer	0.00011	0.000302	CcSEcCtD
Fenofibrate—Decreased appetite—Paclitaxel—kidney cancer	0.00011	0.000302	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—JUNB—kidney cancer	0.00011	0.00285	CbGpPWpGaD
Fenofibrate—Hypertension—Capecitabine—kidney cancer	0.00011	0.000301	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.00011	0.0003	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00011	0.000299	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—EEF2—kidney cancer	0.000109	0.00283	CbGpPWpGaD
Fenofibrate—Fatigue—Paclitaxel—kidney cancer	0.000109	0.000299	CcSEcCtD
Fenofibrate—Diarrhoea—Vincristine—kidney cancer	0.000109	0.000299	CcSEcCtD
Fenofibrate—Pollakiuria—Doxorubicin—kidney cancer	0.000109	0.000298	CcSEcCtD
Fenofibrate—Asthenia—Gemcitabine—kidney cancer	0.000109	0.000297	CcSEcCtD
Fenofibrate—Chest pain—Capecitabine—kidney cancer	0.000109	0.000297	CcSEcCtD
Fenofibrate—Arthralgia—Capecitabine—kidney cancer	0.000109	0.000297	CcSEcCtD
Fenofibrate—Myalgia—Capecitabine—kidney cancer	0.000109	0.000297	CcSEcCtD
Fenofibrate—Constipation—Paclitaxel—kidney cancer	0.000109	0.000297	CcSEcCtD
Fenofibrate—Pain—Paclitaxel—kidney cancer	0.000109	0.000297	CcSEcCtD
Fenofibrate—Anxiety—Capecitabine—kidney cancer	0.000108	0.000296	CcSEcCtD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000108	0.0028	CbGpPWpGaD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000108	0.000295	CcSEcCtD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000108	0.00279	CbGpPWpGaD
Fenofibrate—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000108	0.000295	CcSEcCtD
Fenofibrate—PPARA—Metabolism—GLIPR1—kidney cancer	0.000108	0.00279	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PPAT—kidney cancer	0.000108	0.00279	CbGpPWpGaD
Fenofibrate—Weight increased—Doxorubicin—kidney cancer	0.000107	0.000294	CcSEcCtD
Fenofibrate—Discomfort—Capecitabine—kidney cancer	0.000107	0.000293	CcSEcCtD
Fenofibrate—Pruritus—Gemcitabine—kidney cancer	0.000107	0.000293	CcSEcCtD
Fenofibrate—Weight decreased—Doxorubicin—kidney cancer	0.000107	0.000292	CcSEcCtD
Fenofibrate—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000107	0.00276	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000106	0.00275	CbGpPWpGaD
Fenofibrate—Dry mouth—Capecitabine—kidney cancer	0.000106	0.00029	CcSEcCtD
Fenofibrate—Nausea—Dactinomycin—kidney cancer	0.000106	0.00029	CcSEcCtD
Fenofibrate—Pneumonia—Doxorubicin—kidney cancer	0.000106	0.000289	CcSEcCtD
Fenofibrate—Dizziness—Vincristine—kidney cancer	0.000106	0.000289	CcSEcCtD
Fenofibrate—Infestation—Doxorubicin—kidney cancer	0.000105	0.000288	CcSEcCtD
Fenofibrate—Infestation NOS—Doxorubicin—kidney cancer	0.000105	0.000288	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000105	0.00272	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—TET2—kidney cancer	0.000105	0.00271	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Paclitaxel—kidney cancer	0.000105	0.000286	CcSEcCtD
Fenofibrate—Oedema—Capecitabine—kidney cancer	0.000104	0.000285	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000104	0.000284	CcSEcCtD
Fenofibrate—Diarrhoea—Gemcitabine—kidney cancer	0.000104	0.000283	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—PAK1—kidney cancer	0.000104	0.00268	CbGpPWpGaD
Fenofibrate—Renal failure—Doxorubicin—kidney cancer	0.000103	0.000283	CcSEcCtD
Fenofibrate—Infection—Capecitabine—kidney cancer	0.000103	0.000283	CcSEcCtD
Fenofibrate—Jaundice—Doxorubicin—kidney cancer	0.000103	0.00028	CcSEcCtD
Fenofibrate—Conjunctivitis—Doxorubicin—kidney cancer	0.000102	0.00028	CcSEcCtD
Fenofibrate—Urinary tract infection—Doxorubicin—kidney cancer	0.000102	0.00028	CcSEcCtD
Fenofibrate—Nervous system disorder—Capecitabine—kidney cancer	0.000102	0.000279	CcSEcCtD
Fenofibrate—Thrombocytopenia—Capecitabine—kidney cancer	0.000102	0.000279	CcSEcCtD
Fenofibrate—Tachycardia—Capecitabine—kidney cancer	0.000102	0.000278	CcSEcCtD
Fenofibrate—Vomiting—Vincristine—kidney cancer	0.000102	0.000278	CcSEcCtD
Fenofibrate—Skin disorder—Capecitabine—kidney cancer	0.000101	0.000277	CcSEcCtD
Fenofibrate—Sweating—Doxorubicin—kidney cancer	0.000101	0.000276	CcSEcCtD
Fenofibrate—Urticaria—Paclitaxel—kidney cancer	0.000101	0.000276	CcSEcCtD
Fenofibrate—Rash—Vincristine—kidney cancer	0.000101	0.000275	CcSEcCtD
Fenofibrate—Hyperhidrosis—Capecitabine—kidney cancer	0.000101	0.000275	CcSEcCtD
Fenofibrate—Dermatitis—Vincristine—kidney cancer	0.000101	0.000275	CcSEcCtD
Fenofibrate—Abdominal pain—Paclitaxel—kidney cancer	0.0001	0.000274	CcSEcCtD
Fenofibrate—Body temperature increased—Paclitaxel—kidney cancer	0.0001	0.000274	CcSEcCtD
Fenofibrate—Headache—Vincristine—kidney cancer	0.0001	0.000274	CcSEcCtD
Fenofibrate—PPARA—Metabolism—FH—kidney cancer	0.0001	0.00259	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—APRT—kidney cancer	0.0001	0.00259	CbGpPWpGaD
Fenofibrate—Hepatobiliary disease—Doxorubicin—kidney cancer	9.96e-05	0.000272	CcSEcCtD
Fenofibrate—Anorexia—Capecitabine—kidney cancer	9.93e-05	0.000271	CcSEcCtD
Fenofibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.91e-05	0.00256	CbGpPWpGaD
Fenofibrate—Sinusitis—Doxorubicin—kidney cancer	9.88e-05	0.00027	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	9.78e-05	0.00253	CbGpPWpGaD
Fenofibrate—Hypotension—Capecitabine—kidney cancer	9.73e-05	0.000266	CcSEcCtD
Fenofibrate—Vomiting—Gemcitabine—kidney cancer	9.64e-05	0.000263	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—TCEB1—kidney cancer	9.6e-05	0.00248	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—TCEB2—kidney cancer	9.6e-05	0.00248	CbGpPWpGaD
Fenofibrate—Rash—Gemcitabine—kidney cancer	9.56e-05	0.000261	CcSEcCtD
Fenofibrate—Dermatitis—Gemcitabine—kidney cancer	9.55e-05	0.000261	CcSEcCtD
Fenofibrate—Headache—Gemcitabine—kidney cancer	9.5e-05	0.00026	CcSEcCtD
Fenofibrate—Nausea—Vincristine—kidney cancer	9.49e-05	0.000259	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.49e-05	0.000259	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—GSTT1—kidney cancer	9.48e-05	0.00245	CbGpPWpGaD
Fenofibrate—Rhinitis—Doxorubicin—kidney cancer	9.47e-05	0.000259	CcSEcCtD
Fenofibrate—Hepatitis—Doxorubicin—kidney cancer	9.45e-05	0.000258	CcSEcCtD
Fenofibrate—Insomnia—Capecitabine—kidney cancer	9.42e-05	0.000257	CcSEcCtD
Fenofibrate—PPARA—Metabolism—GPC3—kidney cancer	9.41e-05	0.00243	CbGpPWpGaD
Fenofibrate—Pharyngitis—Doxorubicin—kidney cancer	9.38e-05	0.000256	CcSEcCtD
Fenofibrate—Paraesthesia—Capecitabine—kidney cancer	9.35e-05	0.000256	CcSEcCtD
Fenofibrate—Hypersensitivity—Paclitaxel—kidney cancer	9.35e-05	0.000256	CcSEcCtD
Fenofibrate—Oedema peripheral—Doxorubicin—kidney cancer	9.31e-05	0.000254	CcSEcCtD
Fenofibrate—Connective tissue disorder—Doxorubicin—kidney cancer	9.29e-05	0.000254	CcSEcCtD
Fenofibrate—Dyspnoea—Capecitabine—kidney cancer	9.29e-05	0.000254	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.19e-05	0.00238	CbGpPWpGaD
Fenofibrate—Dyspepsia—Capecitabine—kidney cancer	9.17e-05	0.000251	CcSEcCtD
Fenofibrate—PPARA—Metabolism—CA2—kidney cancer	9.15e-05	0.00237	CbGpPWpGaD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—PTGS2—kidney cancer	9.15e-05	0.00237	CbGpPWpGaD
Fenofibrate—Visual impairment—Doxorubicin—kidney cancer	9.11e-05	0.000249	CcSEcCtD
Fenofibrate—Asthenia—Paclitaxel—kidney cancer	9.11e-05	0.000249	CcSEcCtD
Fenofibrate—Decreased appetite—Capecitabine—kidney cancer	9.05e-05	0.000247	CcSEcCtD
Fenofibrate—Nausea—Gemcitabine—kidney cancer	9e-05	0.000246	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Capecitabine—kidney cancer	8.99e-05	0.000246	CcSEcCtD
Fenofibrate—Fatigue—Capecitabine—kidney cancer	8.98e-05	0.000245	CcSEcCtD
Fenofibrate—Pruritus—Paclitaxel—kidney cancer	8.98e-05	0.000245	CcSEcCtD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	8.98e-05	0.00232	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—CDKN2B—kidney cancer	8.97e-05	0.00232	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ALAD—kidney cancer	8.92e-05	0.00231	CbGpPWpGaD
Fenofibrate—Constipation—Capecitabine—kidney cancer	8.91e-05	0.000243	CcSEcCtD
Fenofibrate—Pain—Capecitabine—kidney cancer	8.91e-05	0.000243	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—PTGS1—kidney cancer	8.88e-05	0.0023	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.87e-05	0.0023	CbGpPWpGaD
Fenofibrate—Eye disorder—Doxorubicin—kidney cancer	8.83e-05	0.000241	CcSEcCtD
Fenofibrate—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	8.83e-05	0.00228	CbGpPWpGaD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.77e-05	0.00227	CbGpPWpGaD
Fenofibrate—Cardiac disorder—Doxorubicin—kidney cancer	8.77e-05	0.00024	CcSEcCtD
Fenofibrate—PPARA—Metabolism—ST3GAL2—kidney cancer	8.71e-05	0.00225	CbGpPWpGaD
Fenofibrate—Diarrhoea—Paclitaxel—kidney cancer	8.68e-05	0.000237	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	8.66e-05	0.00224	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Capecitabine—kidney cancer	8.58e-05	0.000235	CcSEcCtD
Fenofibrate—Angiopathy—Doxorubicin—kidney cancer	8.57e-05	0.000234	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Capecitabine—kidney cancer	8.52e-05	0.000233	CcSEcCtD
Fenofibrate—Mediastinal disorder—Doxorubicin—kidney cancer	8.52e-05	0.000233	CcSEcCtD
Fenofibrate—PPARA—Metabolism—ALDH1A1—kidney cancer	8.51e-05	0.0022	CbGpPWpGaD
Fenofibrate—Arrhythmia—Doxorubicin—kidney cancer	8.44e-05	0.000231	CcSEcCtD
Fenofibrate—Dizziness—Paclitaxel—kidney cancer	8.39e-05	0.000229	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—JUN—kidney cancer	8.36e-05	0.00216	CbGpPWpGaD
Fenofibrate—Alopecia—Doxorubicin—kidney cancer	8.35e-05	0.000228	CcSEcCtD
Fenofibrate—Mental disorder—Doxorubicin—kidney cancer	8.28e-05	0.000226	CcSEcCtD
Fenofibrate—Urticaria—Capecitabine—kidney cancer	8.27e-05	0.000226	CcSEcCtD
Fenofibrate—Abdominal pain—Capecitabine—kidney cancer	8.23e-05	0.000225	CcSEcCtD
Fenofibrate—Body temperature increased—Capecitabine—kidney cancer	8.23e-05	0.000225	CcSEcCtD
Fenofibrate—Malnutrition—Doxorubicin—kidney cancer	8.23e-05	0.000225	CcSEcCtD
Fenofibrate—Erythema—Doxorubicin—kidney cancer	8.23e-05	0.000225	CcSEcCtD
Fenofibrate—PPARA—Metabolism—PGK1—kidney cancer	8.16e-05	0.00211	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—SLC5A3—kidney cancer	8.16e-05	0.00211	CbGpPWpGaD
Fenofibrate—Flatulence—Doxorubicin—kidney cancer	8.11e-05	0.000222	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—PTEN—kidney cancer	8.08e-05	0.00209	CbGpPWpGaD
Fenofibrate—Tension—Doxorubicin—kidney cancer	8.07e-05	0.000221	CcSEcCtD
Fenofibrate—Vomiting—Paclitaxel—kidney cancer	8.07e-05	0.000221	CcSEcCtD
Fenofibrate—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	8.07e-05	0.00209	CbGpPWpGaD
Fenofibrate—CYP2C8—Phase 1 - Functionalization of compounds—POMC—kidney cancer	8.04e-05	0.00208	CbGpPWpGaD
Fenofibrate—Rash—Paclitaxel—kidney cancer	8e-05	0.000219	CcSEcCtD
Fenofibrate—PPARA—Metabolism—LDHB—kidney cancer	8e-05	0.00207	CbGpPWpGaD
Fenofibrate—Dermatitis—Paclitaxel—kidney cancer	7.99e-05	0.000219	CcSEcCtD
Fenofibrate—Nervousness—Doxorubicin—kidney cancer	7.99e-05	0.000218	CcSEcCtD
Fenofibrate—Back pain—Doxorubicin—kidney cancer	7.96e-05	0.000217	CcSEcCtD
Fenofibrate—Headache—Paclitaxel—kidney cancer	7.95e-05	0.000217	CcSEcCtD
Fenofibrate—Muscle spasms—Doxorubicin—kidney cancer	7.91e-05	0.000216	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	7.84e-05	0.00203	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—RPL14—kidney cancer	7.8e-05	0.00202	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—GSTT1—kidney cancer	7.72e-05	0.002	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Capecitabine—kidney cancer	7.67e-05	0.00021	CcSEcCtD
Fenofibrate—Ill-defined disorder—Doxorubicin—kidney cancer	7.63e-05	0.000209	CcSEcCtD
Fenofibrate—Anaemia—Doxorubicin—kidney cancer	7.6e-05	0.000208	CcSEcCtD
Fenofibrate—Nausea—Paclitaxel—kidney cancer	7.54e-05	0.000206	CcSEcCtD
Fenofibrate—Asthenia—Capecitabine—kidney cancer	7.47e-05	0.000204	CcSEcCtD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	7.45e-05	0.00193	CbGpPWpGaD
Fenofibrate—Malaise—Doxorubicin—kidney cancer	7.42e-05	0.000203	CcSEcCtD
Fenofibrate—Vertigo—Doxorubicin—kidney cancer	7.39e-05	0.000202	CcSEcCtD
Fenofibrate—Pruritus—Capecitabine—kidney cancer	7.37e-05	0.000201	CcSEcCtD
Fenofibrate—Leukopenia—Doxorubicin—kidney cancer	7.36e-05	0.000201	CcSEcCtD
Fenofibrate—Palpitations—Doxorubicin—kidney cancer	7.27e-05	0.000199	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—PTGS1—kidney cancer	7.23e-05	0.00187	CbGpPWpGaD
Fenofibrate—Cough—Doxorubicin—kidney cancer	7.18e-05	0.000196	CcSEcCtD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.14e-05	0.00185	CbGpPWpGaD
Fenofibrate—Diarrhoea—Capecitabine—kidney cancer	7.13e-05	0.000195	CcSEcCtD
Fenofibrate—Hypertension—Doxorubicin—kidney cancer	7.1e-05	0.000194	CcSEcCtD
Fenofibrate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.04e-05	0.00182	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—ABCB1—kidney cancer	7e-05	0.00181	CbGpPWpGaD
Fenofibrate—Chest pain—Doxorubicin—kidney cancer	7e-05	0.000191	CcSEcCtD
Fenofibrate—Myalgia—Doxorubicin—kidney cancer	7e-05	0.000191	CcSEcCtD
Fenofibrate—Arthralgia—Doxorubicin—kidney cancer	7e-05	0.000191	CcSEcCtD
Fenofibrate—Anxiety—Doxorubicin—kidney cancer	6.98e-05	0.000191	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.96e-05	0.00019	CcSEcCtD
Fenofibrate—PPARA—Metabolism—CA9—kidney cancer	6.94e-05	0.00179	CbGpPWpGaD
Fenofibrate—Discomfort—Doxorubicin—kidney cancer	6.92e-05	0.000189	CcSEcCtD
Fenofibrate—Dizziness—Capecitabine—kidney cancer	6.89e-05	0.000188	CcSEcCtD
Fenofibrate—Dry mouth—Doxorubicin—kidney cancer	6.85e-05	0.000187	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.78e-05	0.00175	CbGpPWpGaD
Fenofibrate—Oedema—Doxorubicin—kidney cancer	6.71e-05	0.000184	CcSEcCtD
Fenofibrate—Infection—Doxorubicin—kidney cancer	6.67e-05	0.000182	CcSEcCtD
Fenofibrate—Vomiting—Capecitabine—kidney cancer	6.62e-05	0.000181	CcSEcCtD
Fenofibrate—Nervous system disorder—Doxorubicin—kidney cancer	6.58e-05	0.00018	CcSEcCtD
Fenofibrate—Thrombocytopenia—Doxorubicin—kidney cancer	6.57e-05	0.00018	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—GSTP1—kidney cancer	6.57e-05	0.0017	CbGpPWpGaD
Fenofibrate—Rash—Capecitabine—kidney cancer	6.57e-05	0.00018	CcSEcCtD
Fenofibrate—Dermatitis—Capecitabine—kidney cancer	6.56e-05	0.000179	CcSEcCtD
Fenofibrate—Tachycardia—Doxorubicin—kidney cancer	6.55e-05	0.000179	CcSEcCtD
Fenofibrate—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.54e-05	0.00169	CbGpPWpGaD
Fenofibrate—Headache—Capecitabine—kidney cancer	6.52e-05	0.000178	CcSEcCtD
Fenofibrate—Skin disorder—Doxorubicin—kidney cancer	6.52e-05	0.000178	CcSEcCtD
Fenofibrate—Hyperhidrosis—Doxorubicin—kidney cancer	6.49e-05	0.000177	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	6.48e-05	0.00168	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—KDR—kidney cancer	6.45e-05	0.00167	CbGpPWpGaD
Fenofibrate—Anorexia—Doxorubicin—kidney cancer	6.4e-05	0.000175	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	6.38e-05	0.00165	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—EIF4EBP1—kidney cancer	6.36e-05	0.00164	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—HSPB1—kidney cancer	6.36e-05	0.00164	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—MET—kidney cancer	6.32e-05	0.00163	CbGpPWpGaD
Fenofibrate—Hypotension—Doxorubicin—kidney cancer	6.27e-05	0.000171	CcSEcCtD
Fenofibrate—Nausea—Capecitabine—kidney cancer	6.19e-05	0.000169	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.12e-05	0.000167	CcSEcCtD
Fenofibrate—Insomnia—Doxorubicin—kidney cancer	6.07e-05	0.000166	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—GSTM1—kidney cancer	6.04e-05	0.00156	CbGpPWpGaD
Fenofibrate—Paraesthesia—Doxorubicin—kidney cancer	6.03e-05	0.000165	CcSEcCtD
Fenofibrate—Dyspnoea—Doxorubicin—kidney cancer	5.99e-05	0.000164	CcSEcCtD
Fenofibrate—Somnolence—Doxorubicin—kidney cancer	5.97e-05	0.000163	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	5.96e-05	0.00154	CbGpPWpGaD
Fenofibrate—Dyspepsia—Doxorubicin—kidney cancer	5.91e-05	0.000162	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—PSMD7—kidney cancer	5.91e-05	0.00153	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CRABP1—kidney cancer	5.9e-05	0.00153	CbGpPWpGaD
Fenofibrate—Decreased appetite—Doxorubicin—kidney cancer	5.84e-05	0.00016	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.8e-05	0.000158	CcSEcCtD
Fenofibrate—Fatigue—Doxorubicin—kidney cancer	5.79e-05	0.000158	CcSEcCtD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.78e-05	0.0015	CbGpPWpGaD
Fenofibrate—Pain—Doxorubicin—kidney cancer	5.74e-05	0.000157	CcSEcCtD
Fenofibrate—Constipation—Doxorubicin—kidney cancer	5.74e-05	0.000157	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	5.73e-05	0.00148	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	5.65e-05	0.00146	CbGpPWpGaD
Fenofibrate—Feeling abnormal—Doxorubicin—kidney cancer	5.53e-05	0.000151	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—TP53—kidney cancer	5.52e-05	0.00143	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Doxorubicin—kidney cancer	5.49e-05	0.00015	CcSEcCtD
Fenofibrate—PPARA—Metabolism—ITPR2—kidney cancer	5.48e-05	0.00142	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—GSTP1—kidney cancer	5.35e-05	0.00138	CbGpPWpGaD
Fenofibrate—Urticaria—Doxorubicin—kidney cancer	5.33e-05	0.000146	CcSEcCtD
Fenofibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.32e-05	0.00138	CbGpPWpGaD
Fenofibrate—Body temperature increased—Doxorubicin—kidney cancer	5.31e-05	0.000145	CcSEcCtD
Fenofibrate—Abdominal pain—Doxorubicin—kidney cancer	5.31e-05	0.000145	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—JUNB—kidney cancer	5.3e-05	0.00137	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	5.28e-05	0.00136	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTT1—kidney cancer	5.09e-05	0.00132	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.05e-05	0.00131	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ACY1—kidney cancer	5.04e-05	0.0013	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTT1—kidney cancer	5e-05	0.00129	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ACHE—kidney cancer	5e-05	0.00129	CbGpPWpGaD
Fenofibrate—Hypersensitivity—Doxorubicin—kidney cancer	4.95e-05	0.000135	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—GSTM1—kidney cancer	4.92e-05	0.00127	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	4.85e-05	0.00125	CbGpPWpGaD
Fenofibrate—Asthenia—Doxorubicin—kidney cancer	4.82e-05	0.000132	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.77e-05	0.00123	CbGpPWpGaD
Fenofibrate—Pruritus—Doxorubicin—kidney cancer	4.75e-05	0.00013	CcSEcCtD
Fenofibrate—PPARA—Metabolism—SCARB1—kidney cancer	4.73e-05	0.00122	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTGS1—kidney cancer	4.69e-05	0.00121	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—RAF1—kidney cancer	4.67e-05	0.00121	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	4.66e-05	0.00121	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—RELA—kidney cancer	4.65e-05	0.0012	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—ERBB2—kidney cancer	4.62e-05	0.00119	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	4.6e-05	0.00119	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PSMD7—kidney cancer	4.59e-05	0.00119	CbGpPWpGaD
Fenofibrate—Diarrhoea—Doxorubicin—kidney cancer	4.59e-05	0.000126	CcSEcCtD
Fenofibrate—Dizziness—Doxorubicin—kidney cancer	4.44e-05	0.000121	CcSEcCtD
Fenofibrate—PPARA—Metabolism—BCHE—kidney cancer	4.36e-05	0.00113	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—CDKN2B—kidney cancer	4.32e-05	0.00112	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.31e-05	0.00112	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—SLC5A5—kidney cancer	4.3e-05	0.00111	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.29e-05	0.00111	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PDHB—kidney cancer	4.28e-05	0.00111	CbGpPWpGaD
Fenofibrate—Vomiting—Doxorubicin—kidney cancer	4.27e-05	0.000117	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—POMC—kidney cancer	4.27e-05	0.0011	CbGpPWpGaD
Fenofibrate—Rash—Doxorubicin—kidney cancer	4.23e-05	0.000116	CcSEcCtD
Fenofibrate—Dermatitis—Doxorubicin—kidney cancer	4.23e-05	0.000116	CcSEcCtD
Fenofibrate—Headache—Doxorubicin—kidney cancer	4.21e-05	0.000115	CcSEcCtD
Fenofibrate—PPARA—Metabolism—SLC2A1—kidney cancer	4.16e-05	0.00108	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ACY1—kidney cancer	4.1e-05	0.00106	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—CTNNB1—kidney cancer	4.04e-05	0.00105	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.03e-05	0.00104	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CCBL1—kidney cancer	4.03e-05	0.00104	CbGpPWpGaD
Fenofibrate—Nausea—Doxorubicin—kidney cancer	3.99e-05	0.000109	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—RAF1—kidney cancer	3.96e-05	0.00103	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.64e-05	0.000942	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—VEGFA—kidney cancer	3.56e-05	0.00092	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.53e-05	0.000913	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.52e-05	0.00091	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.5e-05	0.000904	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PPAT—kidney cancer	3.49e-05	0.000903	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GLIPR1—kidney cancer	3.49e-05	0.000903	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PDHB—kidney cancer	3.48e-05	0.000902	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.48e-05	0.0009	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—MYC—kidney cancer	3.48e-05	0.000899	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—POMC—kidney cancer	3.47e-05	0.000899	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTP1—kidney cancer	3.47e-05	0.000897	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.45e-05	0.000892	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.41e-05	0.000883	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—MAPK3—kidney cancer	3.36e-05	0.00087	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ABCB1—kidney cancer	3.28e-05	0.000849	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CCBL1—kidney cancer	3.28e-05	0.000848	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—FH—kidney cancer	3.25e-05	0.00084	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—APRT—kidney cancer	3.25e-05	0.00084	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.24e-05	0.000839	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—MAPK1—kidney cancer	3.2e-05	0.000828	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.2e-05	0.000827	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTM1—kidney cancer	3.18e-05	0.000824	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.17e-05	0.000821	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.07e-05	0.000795	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GPC3—kidney cancer	3.05e-05	0.000789	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.03e-05	0.000784	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—KRAS—kidney cancer	3.02e-05	0.000782	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP1A1—kidney cancer	3.02e-05	0.000781	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CA2—kidney cancer	2.97e-05	0.000768	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.96e-05	0.000767	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALAD—kidney cancer	2.89e-05	0.000748	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PPAT—kidney cancer	2.84e-05	0.000735	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.84e-05	0.000735	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ST3GAL2—kidney cancer	2.82e-05	0.00073	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.8e-05	0.000726	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.78e-05	0.000718	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.76e-05	0.000714	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ACY1—kidney cancer	2.7e-05	0.000699	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PGK1—kidney cancer	2.65e-05	0.000684	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SLC5A3—kidney cancer	2.65e-05	0.000684	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—FH—kidney cancer	2.64e-05	0.000683	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—APRT—kidney cancer	2.64e-05	0.000683	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—LDHB—kidney cancer	2.59e-05	0.000671	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.58e-05	0.000668	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GPC3—kidney cancer	2.48e-05	0.000642	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.48e-05	0.000642	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CA2—kidney cancer	2.42e-05	0.000625	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALAD—kidney cancer	2.35e-05	0.000609	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PDHB—kidney cancer	2.3e-05	0.000595	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.3e-05	0.000594	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—POMC—kidney cancer	2.29e-05	0.000593	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—POMC—kidney cancer	2.25e-05	0.000582	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CA9—kidney cancer	2.25e-05	0.000582	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.25e-05	0.000581	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.2e-05	0.000569	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CCBL1—kidney cancer	2.16e-05	0.000559	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PGK1—kidney cancer	2.15e-05	0.000557	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.15e-05	0.000557	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—LDHB—kidney cancer	2.11e-05	0.000546	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CRABP1—kidney cancer	1.91e-05	0.000495	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PPAT—kidney cancer	1.87e-05	0.000485	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.87e-05	0.000485	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CA9—kidney cancer	1.83e-05	0.000474	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTGS2—kidney cancer	1.8e-05	0.000465	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.79e-05	0.000463	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ITPR2—kidney cancer	1.78e-05	0.00046	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—FH—kidney cancer	1.74e-05	0.000451	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—APRT—kidney cancer	1.74e-05	0.000451	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MAPK3—kidney cancer	1.72e-05	0.000445	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MYC—kidney cancer	1.67e-05	0.000433	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.64e-05	0.000424	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GPC3—kidney cancer	1.64e-05	0.000424	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTT1—kidney cancer	1.62e-05	0.00042	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ACHE—kidney cancer	1.62e-05	0.00042	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CA2—kidney cancer	1.59e-05	0.000412	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTEN—kidney cancer	1.57e-05	0.000405	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CRABP1—kidney cancer	1.56e-05	0.000403	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALAD—kidney cancer	1.55e-05	0.000402	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SCARB1—kidney cancer	1.53e-05	0.000397	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTGS1—kidney cancer	1.52e-05	0.000393	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.52e-05	0.000392	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PSMD7—kidney cancer	1.49e-05	0.000386	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.48e-05	0.000383	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ITPR2—kidney cancer	1.45e-05	0.000374	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PGK1—kidney cancer	1.42e-05	0.000367	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.42e-05	0.000367	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—BCHE—kidney cancer	1.41e-05	0.000365	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.4e-05	0.000361	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—LDHB—kidney cancer	1.39e-05	0.00036	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.35e-05	0.000349	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.33e-05	0.000345	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTT1—kidney cancer	1.32e-05	0.000341	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ACHE—kidney cancer	1.32e-05	0.000341	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.31e-05	0.000338	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SCARB1—kidney cancer	1.25e-05	0.000323	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTGS1—kidney cancer	1.24e-05	0.00032	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PSMD7—kidney cancer	1.21e-05	0.000314	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CA9—kidney cancer	1.21e-05	0.000312	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—BCHE—kidney cancer	1.15e-05	0.000297	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.14e-05	0.000295	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.14e-05	0.000294	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTP1—kidney cancer	1.12e-05	0.000291	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PIK3CA—kidney cancer	1.1e-05	0.000286	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.000284	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.06e-05	0.000275	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ABCB1—kidney cancer	1.06e-05	0.000275	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTM1—kidney cancer	1.03e-05	0.000267	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CRABP1—kidney cancer	1.03e-05	0.000266	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP1A1—kidney cancer	9.79e-06	0.000253	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ITPR2—kidney cancer	9.54e-06	0.000247	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.28e-06	0.00024	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTP1—kidney cancer	9.15e-06	0.000237	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTT1—kidney cancer	8.7e-06	0.000225	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ACHE—kidney cancer	8.7e-06	0.000225	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ABCB1—kidney cancer	8.66e-06	0.000224	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTM1—kidney cancer	8.41e-06	0.000217	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SCARB1—kidney cancer	8.24e-06	0.000213	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTGS1—kidney cancer	8.16e-06	0.000211	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.04e-06	0.000208	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PSMD7—kidney cancer	8e-06	0.000207	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP1A1—kidney cancer	7.97e-06	0.000206	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—BCHE—kidney cancer	7.58e-06	0.000196	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.49e-06	0.000194	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—POMC—kidney cancer	7.3e-06	0.000189	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.23e-06	0.000187	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.55e-06	0.000169	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTP1—kidney cancer	6.03e-06	0.000156	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—POMC—kidney cancer	5.94e-06	0.000154	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTGS2—kidney cancer	5.82e-06	0.000151	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ABCB1—kidney cancer	5.71e-06	0.000148	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTM1—kidney cancer	5.54e-06	0.000143	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.26e-06	0.000136	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTEN—kidney cancer	5.08e-06	0.000131	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTGS2—kidney cancer	4.74e-06	0.000123	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTEN—kidney cancer	4.13e-06	0.000107	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—POMC—kidney cancer	3.92e-06	0.000101	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.58e-06	9.27e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTGS2—kidney cancer	3.13e-06	8.09e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.92e-06	7.54e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTEN—kidney cancer	2.73e-06	7.05e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.92e-06	4.97e-05	CbGpPWpGaD
